Publications by authors named "Huaiping Tang"

Claim this Profile
C
Corrigendum to "Broxyquinoline targets NLRP3 to inhibit inflammasome activation and alleviate NLRP3-associated inflammatory diseases" [Int. Immunopharmacol. 156 (2025) 114687].
Huaiping Tang, Xinxin Zou, Peipei Chen, Yunshu Wang, Shenghan Gao

Int Immunopharmacol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broxyquinoline targets NLRP3 to inhibit inflammasome activation and alleviate NLRP3-associated inflammatory diseases.
Huaiping Tang, Xinxin Zou, Peipei Chen, Yunshu Wang, Shenghan Gao

Int Immunopharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New applications of clioquinol in the treatment of inflammation disease by directly targeting arginine 335 of NLRP3.
Peipei Chen, Yunshu Wang, Huaiping Tang, Chao Zhou, Zhuo Liu

J Pharm Anal· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrodenol suppresses NLRP3/GSDMD mediated pyroptosis and ameliorates inflammatory diseases.
Peipei Chen, Yunshu Wang, Huaiping Tang, Zhuo Liu, Jing Wang

Cell Immunol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitory Role of an TIR Domain Effector in Antibacterial Immunity by Targeting TLR Signaling Complexes in Zebrafish.
Huai-Ping Tang, Chen Huang, Chong-Bin Hu, Hao Li, Tong Shao

Front Microbiol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis